๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

960 Phase I trial of a new nitrosurea in a weekly schedule

โœ Scribed by C. Terret; E. Goncalves; L. Da Costa; V. Urosevic; P. Chollet; J. Madelmont; J.P. Armand

Book ID
116167705
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
304 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase i-ii study of maytansine utilizi
A phase i-ii study of maytansine utilizing a weekly schedule
โœ Roman Franklin; Michael K. Samson; Roberto J. Fraile; Hakam Abu-Zahra; Robert O' ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 428 KB ๐Ÿ‘ 2 views

Maytansine, a new ansa macrolide antitumor antibiotic, was administered to a total of 107 patients in a Phase 1-11 study. Dose-limiting toxic reactions which occurred at 0.75-1.0 mg/M' in both Phase I and I1 were neurologic and consisted primarily of lethargylweakness (a debilitation syndrome) and p

Phase I study of oral menogaril administ
Phase I study of oral menogaril administered on a once weekly schedule
โœ David J. Stewart; Shailendra Verma; Jean A. Maroun; Lucille Robillard; Robert H. ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 741 KB

Forty-seven patients with solid tumors were treated on a phase I study of menogaril administered by mouth once per week. Nausea and vomiting were excessive at weekly doses of 350 and 450 mg/m2/week but were tolerable and controlled reasonably well by antiemetics at lower doses. There appeared to be